Published by
@ShahidNShah
@ShahidNShah
3rd LNP Immunogenicity & Toxicity Summit is held on December 9-11 in Boston, MA.With the applications of LNPs rapidly expanding beyond vaccines, as well as beyond the liver, it is of utmost importance to predict and minimize adverse reactions to guarantee patient safety in the clinic, especially following a clinical hold on Verve Therapeutics' gene therapy earlier this year, due to safety concerns surrounding the LNP delivery system.Returning in December, the 3rd LNP Immunogenicity and Toxicity Summit will return as your unique forum uniting industry experts striving to measure, predict and monitor non-clinical and clinical safety risk for lipid nanoparticles to ensure regulatory compliance for vaccines, gene and cell therapies.
[Read on lnp-immunogenicity-](https://lnp-immunogenicity-toxicity-summit.com/take-part/register/?utm_source=external&utm_medium=event-listing&utm_campaign=event-listing&utm_content=media-partner/evvnt/paid/ev-47493)
Continue reading at lnp-immunogenicity-toxicity-summit.com
December 10 to December 12, 2024
Hilton Boston Logan Airport, One Hotel Drive, Boston, Massachusetts, 02128, United States
Connecting innovation decision makers to authoritative information, institutions, people and insights.
Medigy accurately delivers healthcare and technology information, news and insight from around the world.
Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.
© 2024 Netspective Media LLC. All Rights Reserved.
Built on Sep 13, 2024 at 11:52am